{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:55:29Z","timestamp":1791590129597,"version":"4.3.4"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>There has been steady progress in understanding the pathogenesis, clinical features, and effective treatment of acute anterior uveitis (AU) over the past 5 years. Large gene wide association studies have confirmed that AU is a polygenic disease, with overlaps with the seronegative arthropathies and inflammatory bowel diseases, associations that have been repeatedly confirmed in clinical studies. The role of the microbiome in AU has received increased research attention, with recent evidence indicating that human leukocyte antigen B27 (HLA B27) may influence the composition of the gut microbiome in experimental animals. Extensive clinical investigations have confirmed the typical features of acute AU (AAU) and its response to topical, regional and systemic immunosuppressive treatment. Increased understanding of the role of cytokines has resulted in studies confirming the value of anti-cytokine therapy [anti\u2013tumor necrosis factor (anti-TNF) and interleukin 6 (IL-6) therapy] in severe and recurrent cases of AAU, particularly in subjects with an associated spondyloarthopathy (SpA) and in juvenile idiopathic arthritis (JIA)\u2013associated AAU.<\/jats:p>","DOI":"10.3389\/fimmu.2020.608134","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T04:31:32Z","timestamp":1609821092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["Recent Developments in HLA B27 Anterior Uveitis"],"prefix":"10.3389","volume":"11","author":[{"given":"Denis","family":"Wakefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/02713689208999505","article-title":"The epidemiology and genetics of endogenous uveitis: a review","author":"Baarsma","year":"1992","journal-title":"Curr Eye Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iio.0000155938.83083.94","article-title":"Epidemiology of Uveitis","volume":"45","author":"Wakefield","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-018-0148-5","article-title":"Epidemiology of uveitis in a US population-based study","volume":"8","author":"Gonz\u00e1lez","year":"2018","journal-title":"J Ophthalmic Inflammation Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1175642","article-title":"Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders","volume":"24","author":"Kopplin","year":"2016","journal-title":"Ocul Immunol Inflammation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181637a38","article-title":"HLA-B27 and its pathogenic role","volume":"14","author":"Khan","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2011.559302","article-title":"An update on the genetics of HLA-B27 associated acute anterior uveitis","volume":"19","author":"Martin","year":"2011","journal-title":"Ocul Immunol Inflammation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.2859","article-title":"Op0262 Factors Associated with Acute Anterior Uveitis in Patients with Axial Spondyloarthritis: Analysis of the Bsrbr-as Register Database","volume":"78","author":"Derakhshan","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bjophthalmol-2016-309499","article-title":"Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort","volume":"102","author":"Yang","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1076\/ocii.7.2.85.4015","article-title":"Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics","volume":"7","author":"Dodds","year":"1999","journal-title":"Ocul Immunol Inflammation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)74218-7","article-title":"Clinical features of acute anterior uveitis","volume":"103","author":"Rothova","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1247174","article-title":"Complications of Uveitis: The Northern California Epidemiology of Uveitis Study","volume":"26","author":"Gritz","year":"2018","journal-title":"Ocul Immunol Inflammation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/08820538.2016.1170158","article-title":"Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis","volume":"32","author":"D\u2019Ambrosio","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(88)90051-7","article-title":"A familial study of the inheritance of HLA-B27-positive acute anterior uveitis","volume":"105","author":"Derhaag","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.38873","article-title":"Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis","volume":"67","author":"Robinson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.6.3","article-title":"Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci","volume":"61","author":"Huang","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.066241","article-title":"The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion","volume":"16","author":"Barnea","year":"2017","journal-title":"Mol Cell Proteomics MCP"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.40028","article-title":"Discovery of T Cell Receptor beta Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis","volume":"69","author":"Faham","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/03009740902769559","article-title":"Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000","volume":"38","author":"Savolainen","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.24431","article-title":"Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis","volume":"60","author":"Carter","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B22","article-title":"Bacterial triggers and autoimmune rheumatic diseases","volume":"26","author":"Girschick","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2008.00524.x","article-title":"Detection and frequency of Chlamydia trachomatis DNA in synovial samples from Tunisian patients with reactive arthritis and undifferentiated oligoarthritis","volume":"55","author":"Siala","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0968-z","article-title":"Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis","volume":"28","author":"Kuipers","year":"2009","journal-title":"Clin Rheumatol"},{"key":"B25","article-title":"Correlations between infection patterns and eye damage in reactive arthritis","volume":"60","author":"Banicioiu-Covei","year":"2019","journal-title":"Rom J Morphol Embryol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2015.10.011","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: Prevalence and associated phenotype","volume":"83","author":"Maillet","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B27","first-page":"49","article-title":"Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27","volume":"63","author":"Wakefield","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)91089-1","article-title":"HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies","volume":"345","author":"Scofield","year":"1995","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90385-3","article-title":"Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies","volume":"85","author":"Schwimmbeck","year":"1988","journal-title":"Am J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-2249.1991.tb02944.x","article-title":"Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix","volume":"86","author":"Lahesmaa","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.07.014","article-title":"Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site","volume":"43","author":"Horai","year":"2015","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M115.056358","article-title":"Human Leukocyte Antigen (HLA) B27 Allotype-Specific Binding and Candidate Arthritogenic Peptides Revealed through Heuristic Clustering of Data-independent Acquisition Mass Spectrometry (DIA-MS) Data","volume":"15","author":"Schittenhelm","year":"2016","journal-title":"Mol Cell Proteomics MCP"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/art.38963","article-title":"Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes","volume":"67","author":"Schittenhelm","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0097-2","article-title":"The Microbiome and HLA B27-associated acute anterior uveitis","volume":"14","author":"Rosenbaum","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5145","article-title":"The role of the gut microbiome in systemic inflammatory disease","volume":"360","author":"Clemente","year":"2018","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2016.1142574","article-title":"Does the microbiome cause B27-related acute anterior uveitis","volume":"24","author":"Rosenbaum","year":"2016","journal-title":"Ocul Immunol Inflammation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105684","article-title":"HLA-B27 and Human \u03b22-Microglobulin Affect the Gut Microbiota of Transgenic Rats","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"B39","article-title":"Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6","volume":"33","author":"Hoekzema","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0807","article-title":"Changes in Toll-like Receptor (TLR)-2 and TLR4 Expression and Function but Not Polymorphisms Are Associated with Acute Anterior Uveitis","volume":"48","author":"Chang","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular Mimicry as a Mechanism of Autoimmune Disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00417","article-title":"The Microbiota and Epigenetic Regulation of T Helper 17\/Regulatory T Cells: In Search of a Balanced Immune System","volume":"8","author":"Luo","year":"2017","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases","volume":"5","author":"Bodis","year":"2018","journal-title":"Rheumatol Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070040071033","article-title":"Serologic evidence of Yersinia infection in patients with anterior uveitis","volume":"108","author":"Wakefield","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/283782a0","article-title":"A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component","volume":"283","author":"Geczy","year":"1980","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.20.9330","article-title":"A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution","volume":"90","author":"Scofield","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","first-page":"1847","article-title":"The role of Chlamydia in HLA-B27 Acute Anterior Uveitis and Seronegative Arthritis Amjadi S, Robertson P, McCluskey PJ, Wakefield D","volume":"56","author":"Amjadi","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.8.4859","article-title":"Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy","volume":"173","author":"Kuon","year":"2004","journal-title":"J Immunol"},{"key":"B49","article-title":"Molecular mimicry\u2013hypothesis or reality","volume":"157","author":"Tsuchiya","year":"1992","journal-title":"West J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.preteyeres.2018.01.001","article-title":"Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye","volume":"64","author":"Wen","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13835","article-title":"The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA-B27-associated uveitis","volume":"97","author":"Abu El-Asrar","year":"2019","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2019.1704022","article-title":"Tear IL-6 and IL-10 levels in HLA-B27-Associated Uveitis and Its clinical Implications","volume":"28","author":"Kumar","year":"2020","journal-title":"Ocul Immunol Inflammation"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19758","article-title":"The Cytokine Interleukin-6 and the Chemokines CCL20 and CXCL13 Are Novel Biomarkers of Specific Endogenous Uveitic Entities","volume":"57","author":"Abu El-Asrar","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/092739490500282","article-title":"Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies","volume":"12","author":"Perez","year":"2004","journal-title":"Ocul Immunol Inflammation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2019.1604974","article-title":"Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities","volume":"27","author":"Abu El-Asrar","year":"2019","journal-title":"Ocul Immunol Inflammation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/08977190410001715181","article-title":"New IL-6 (gp130) family cytokine members, CLC\/NNT1\/BSF3 and IL-27","volume":"22","author":"Murakami","year":"2004","journal-title":"Growth Factors"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2174\/1566524018666180207152941","article-title":"Elevated Interleukin 37 Expression Associated With Disease Activity in HLA-B27 Associated Anterior Uveitis and Idiopathic Anterior Uveitis","volume":"17","author":"Zhao","year":"2018","journal-title":"Curr Mol Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.8.4738","article-title":"Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases","volume":"167","author":"Kuon","year":"2001","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2019.1686156","article-title":"Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis","volume":"27","author":"Huang","year":"2019","journal-title":"Ocul Immunol Inflammation"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2567-9","article-title":"The expression and significance of T helper cell subsets and regulatory T cells CD(4)(+) CD(2)(5)(+) in peripheral blood of patients with human leukocyte antigen B27-positive acute anterior uveitis","volume":"252","author":"Zou","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.01.014","article-title":"Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"139","author":"El-Asrar","year":"2011","journal-title":"Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01773","article-title":"The Phenotype of Monocytes in Anterior Uveitis Depends on the HLA-B27 Status","volume":"9","author":"Kasper","year":"2018","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200408000-00003","article-title":"Review of immunosuppressive drug therapy in uveitis","volume":"15","author":"Dunn","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"key":"B67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajo.2019.10.032","article-title":"Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis","volume":"211","author":"Sheppard","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Multicenter Uveitis Steroid Treatment Trial Research Group. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/14651858.CD010469.pub2","article-title":"Corticosteroid implants for chronic non-infectious uveitis","author":"Brady","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2017.5103","article-title":"Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis","volume":"317","author":"Kempen","year":"2017","journal-title":"JAMA"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate Mofetil for Ocular Inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for Ocular Inflammatory Diseases","volume":"117","author":"Ka\u00e7maz","year":"2010","journal-title":"Ophthalmology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for Ocular Inflammatory Diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-4082-x","article-title":"The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study","volume":"256","author":"zu Hoerste","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1998.0197","article-title":"Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis","volume":"11","author":"Dick","year":"1998","journal-title":"J Autoimmun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.08.003","article-title":"Mechanisms of TNF\u03b1 regulation in uveitis: focus on RNA-binding proteins","volume":"29","author":"Khera","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.34.22128","article-title":"Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells","volume":"273","author":"Giraudo","year":"1998","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B82","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis","volume":"87","author":"Reddy","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210931","article-title":"Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register","volume":"76","author":"Lie","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(02)01292-7","article-title":"Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis","volume":"109","author":"El-Shabrawi","year":"2002","journal-title":"Ophthalmology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0239-y","article-title":"Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis","volume":"37","author":"Yazgan","year":"2017","journal-title":"Int Ophthalmol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.967779","article-title":"Certolizumab Pegol, a New Anti-TNF-\u03b1 in the Armamentarium against Ocular Inflammation","volume":"24","author":"Lloren\u00e7","year":"2016","journal-title":"Ocul Immunol Inflammation"},{"key":"B89","unstructured":"HiltunenJ\n          The Role of Gut Microbiota in the Pathogenesis of Ankylosing Spondylitis (AS), and the Effect of Fecal Microbiota Transplantation on Gut Microbiota, Gut Wall Inflammation and Clinical Activity of AS. clinicaltrials.gov2019"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.4.722","article-title":"Clinical Features and Prognosis of HLA-B27 Positive and Negative Anterior Uveitis in a Korean Population","volume":"24","author":"Park","year":"2009","journal-title":"J Korean Med Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.608134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T04:31:43Z","timestamp":1609821103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.608134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":92,"alternative-id":["10.3389\/fimmu.2020.608134"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.608134","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"article-number":"608134"}}